Screener
PP&E (Net) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Inventory | 70,930 | 54,895 |
| Prepaid expenses and other current assets | 48,285 | 42,614 |
| Total current assets | 668,633 | 527,177 |
| Property and equipment, net | 2,575 | 1,943 |
| Operating lease right-of-use assets | 8,353 | 9,807 |
| Other long-term assets | 10,834 | 11,307 |
| Intangible asset, net | 14,750 | 15,250 |
| Deferred tax assets | 190,965 | 198,149 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Kiniksa Pharmaceuticals International, plc's PP&E (net)?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported PP&E (net) of $2.58M in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's PP&E (net) changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's PP&E (net) increased by 139.3% year-over-year, from $1.08M to $2.58M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's PP&E (net)?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's PP&E (net) has grown at a -13.7% compound annual growth rate (CAGR), from $4.05M to $1.94M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Kiniksa Pharmaceuticals International, plc's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude